Artesunate Exerts a Direct Effect on Endothelial Cell Activation and NF-B Translocation in a Mechanism Independent of Plasmodium Killing
Open Access
- 11 October 2012
- journal article
- research article
- Published by Wiley in Malaria Research and Treatment
- Vol. 2012, 1-12
Abstract
Artemisinin and its derivates are an important class of antimalarial drug and are described to possess immunomodulatory activities. Few studies have addressed the effect of artesunate in the murine malaria model or its effect on host immune response during malaria infection. Herein, we study the effect of artesunate treatment and describe an auxiliary mechanism of artesunate in modulating the inflammatory response during experimental malaria infection in mice. Treatment with artesunate did not reduce significantly the parasitemia within 12 h, however, reduced BBB breakdown and TNF-α mRNA expression in the brain tissue of artesunate-treated mice. Conversely, mefloquine treatment was not able to alter clinical features. Notably, artesunate pretreatment failed to modulate the expression of LFA-1 in splenocytes stimulated with parasitized red blood cells (pRBCs) in vitro; however, it abrogated the expression of ICAM-1 in pRBC-stimulated endothelial cells. Accordingly, a cytoadherence in vitro assay demonstrated that pRBCs did not adhere to artesunate-treated vascular endothelial cells. In addition, NF-κB nuclear translocation in endothelial cells stimulated with pRBCs was impaired by artesunate treatment. Our results suggest that artesunate is able to exert a protective effect against the P. berghei-induced inflammatory response by inhibiting NF-κB nuclear translocation and the subsequent expression of ICAM-1.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- Fundação Oswaldo Cruz
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
This publication has 43 references indexed in Scilit:
- Artemether and Artesunate Show the Highest Efficacies in Rescuing Mice with Late-Stage Cerebral Malaria and Rapidly Decrease Leukocyte Accumulation in the BrainAntimicrobial Agents and Chemotherapy, 2011
- Immune-Mediated Mechanisms of Parasite Tissue Sequestration during Experimental Cerebral MalariaThe Journal of Immunology, 2010
- Cerebral malaria: why experimental murine models are required to understand the pathogenesis of diseaseParasitology, 2009
- Plasmodium falciparum–infected erythrocytes induce NF-κB regulated inflammatory pathways in human cerebral endotheliumBlood, 2009
- Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-κB activationInternational Immunopharmacology, 2008
- Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malariaNature Medicine, 2007
- Anti-malarial agent artesunate inhibits TNF- -induced production of proinflammatory cytokines via inhibition of NF- B and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytesRheumatology, 2007
- Artesunate and a major metabolite, dihydroartemisinin, diminish mitogen-induced lymphocyte proliferation and activation.2006
- Direct Activation of Human Endothelial Cells by Plasmodium falciparum -Infected ErythrocytesInfection and Immunity, 2005
- Clinical Pharmacology and Therapeutic Potential of Artemisinin and its Derivatives in the Treatment of MalariaDrugs, 1996